Introduction
Antiviral medicines are essential in the treatment and management of viral infections such as HIV, HBV, HCV, Influenza, CMV, HSV, VZV, and COVID-19. At Nirvana Pharma, we distribute a wide range of certified antivirals, including NRTIs, NNRTIs, protease inhibitors, integrase inhibitors, polymerase inhibitors, and neuraminidase inhibitors.
All products are sourced from licensed manufacturers to ensure authenticity, safety, and compliance.
📋 Antiviral Product Catalogue
HIV Management
| Drug Name |
Classification |
Common Strengths |
Primary Use |
| Zidovudine (AZT) |
NRTI |
100 mg, 300 mg tab; 10 mg/mL soln; 200 mg cap |
HIV |
| Lamivudine (3TC) |
NRTI |
150 mg, 300 mg tab; 10 mg/mL soln |
HIV, HBV |
| Tenofovir disoproxil fumarate (TDF) |
NRTI |
300 mg tab |
HIV, HBV |
| Tenofovir alafenamide (TAF) |
NRTI |
25 mg tab |
HIV, HBV |
| Emtricitabine (FTC) |
NRTI |
200 mg cap; 10 mg/mL soln |
HIV |
| Abacavir (ABC) |
NRTI |
300 mg tab; 20 mg/mL soln |
HIV |
| Efavirenz (EFV) |
NNRTI |
200 mg, 600 mg tab |
HIV |
| Nevirapine (NVP) |
NNRTI |
200 mg tab; 50 mg/5mL susp |
HIV |
| Raltegravir (RAL) |
Integrase inhibitor |
400 mg tab; 100 mg chewable tab |
HIV |
| Dolutegravir (DTG) |
Integrase inhibitor |
50 mg tab |
HIV |
| Lopinavir + Ritonavir (LPV/r) |
PI |
200/50 mg tab; 80/20 mg/mL soln |
HIV |
| Atazanavir (ATV) |
PI |
150 mg, 200 mg, 300 mg cap |
HIV |
| Darunavir (DRV) |
PI |
75 mg, 150 mg, 300 mg, 600 mg tab |
HIV |
Fixed-Dose Oral Combinations (FDCs)
| Combination (Generic) |
Brand Name(s) |
| Abacavir + Lamivudine (ABC/3TC) |
Epzicom |
| Abacavir + Lamivudine + Zidovudine (ABC/3TC/ZDV) |
Trizivir |
| Bictegravir + Emtricitabine + Tenofovir alafenamide (BIC/FTC/TAF) |
Biktarvy |
| Darunavir + Cobicistat + Emtricitabine + Tenofovir alafenamide (DRV/COBI/FTC/TAF) |
Symtuza |
| Dolutegravir + Abacavir + Lamivudine (DTG/ABC/3TC) |
Triumeq, Triumeq PD |
| Dolutegravir + Lamivudine (DTG/3TC) |
Dovato |
| Dolutegravir + Rilpivirine (DTG/RPV) |
Juluca |
| Doravirine + Lamivudine + Tenofovir disoproxil fumarate (DOR/3TC/TDF) |
Delstrigo |
| Efavirenz + Emtricitabine + Tenofovir disoproxil fumarate (EFV/FTC/TDF) |
Atripla |
| Efavirenz + Lamivudine + Tenofovir disoproxil fumarate (EFV/3TC/TDF) |
Symfi, Symfi Lo |
| Elvitegravir + Cobicistat + Emtricitabine + Tenofovir alafenamide (ECF/TAF) |
Genvoya |
| Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil fumarate (ECF/TDF) |
Stribild |
| Lamivudine + Tenofovir disoproxil fumarate (3TC/TDF) |
Cimduo |
| Rilpivirine + Emtricitabine + Tenofovir alafenamide (RPV/FTC/TAF) |
Odefsey |
| Rilpivirine + Emtricitabine + Tenofovir disoproxil fumarate (RPV/FTC/TDF) |
Complera |
| Tenofovir alafenamide + Emtricitabine (TAF/FTC) |
Descovy |
| Tenofovir disoproxil fumarate + Emtricitabine (TDF/FTC) |
Truvada |
| Zidovudine + Lamivudine (ZDV/3TC) |
Combivir |
Injectable Combination
| Combination (Generic) |
Brand Name |
| Cabotegravir + Rilpivirine (CAB/RPV; extended-release injectable formulation) |
Cabenuva |
Herpes Virus (HSV, VZV)
| Drug Name |
Classification |
Common Strengths |
Primary Use |
| Acyclovir |
Anti-Herpes |
200 mg, 400 mg, 800 mg tab; 200 mg/5mL susp; IV 50 mg/mL |
HSV, VZV |
| Valacyclovir |
Anti-Herpes |
500 mg, 1000 mg tab |
HSV, VZV |
| Famciclovir |
Anti-Herpes |
125 mg, 250 mg, 500 mg tab |
HSV, VZV |
CMV (Cytomegalovirus)
| Drug Name |
Classification |
Common Strengths |
Primary Use |
| Ganciclovir |
Anti-CMV |
250 mg, 500 mg IV inj |
CMV |
| Valganciclovir |
Anti-CMV |
450 mg tab |
CMV |
| Cidofovir |
Anti-CMV |
375 mg/5mL IV |
CMV |
Hepatitis B Virus (HBV)
| Drug Name |
Classification |
Common Strengths |
Primary Use |
| Entecavir |
Polymerase inhibitor |
0.5 mg, 1 mg tab; 0.05 mg/mL soln |
HBV |
| Adefovir dipivoxil |
Polymerase inhibitor |
10 mg tab |
HBV |
| Telbivudine |
Polymerase inhibitor |
600 mg tab |
HBV |
Hepatitis C Virus (HCV)
| Drug Name |
Classification |
Common Strengths |
Primary Use |
| Sofosbuvir |
NS5B inhibitor |
400 mg tab |
HCV |
| Ledipasvir + Sofosbuvir |
NS5A + NS5B inhibitor |
90/400 mg tab |
HCV |
| Daclatasvir |
NS5A inhibitor |
30 mg, 60 mg tab |
HCV |
| Velpatasvir + Sofosbuvir |
NS5A + NS5B inhibitor |
100/400 mg tab |
HCV |
| Glecaprevir + Pibrentasvir |
PI + NS5A inhibitor |
100/40 mg tab |
HCV |
| Ribavirin |
Broad-spectrum |
200 mg cap; 200 mg, 400 mg tab |
HCV, RSV |
Influenza
| Drug Name |
Classification |
Common Strengths |
Primary Use |
| Oseltamivir |
Neuraminidase inhibitor |
30, 45, 75 mg cap; 6 mg/mL susp |
Influenza |
| Zanamivir |
Neuraminidase inhibitor |
5 mg inhalation |
Influenza |
| Peramivir |
Neuraminidase inhibitor |
200 mg IV |
Influenza |
| Baloxavir marboxil |
Endonuclease inhibitor |
20 mg, 40 mg tab |
Influenza |
Broad-Spectrum Antivirals
| Drug Name |
Classification |
Common Strengths |
Primary Use |
| Remdesivir |
Broad-spectrum |
100 mg IV vial |
COVID-19 |
| Favipiravir |
Broad-spectrum |
200 mg tab |
Influenza, COVID-19* |
Closing Note
Nirvana Pharma ensures the availability of critical antiviral medicines to pharmacies, hospitals, and healthcare providers. For bulk inquiries or partnerships, please contact our distribution team for a customized catalogue and pricing.
